Skip to main content
Dx & Vx Co., Ltd. logo

Dx & Vx Co., Ltd. — Investor Relations & Filings

Ticker · 180400 ISIN · KR7180400004 KO Manufacturing
Open in API
Filings indexed 474 across all filing types
Latest filing 2025-04-15 Capital/Financing Update
Country KR South Korea
Listing KO 180400

About Dx & Vx Co., Ltd.

https://www.dxvx.com/

Dx & Vx Co., Ltd. is a bio-healthcare company specializing in diagnostics and vaccine development. Its diagnostics division offers molecular diagnostic solutions, genomics and bioinformatics services, and customized companion diagnostics (CDx), leveraging an AI-based genome analysis platform. The company's therapeutic pipeline is centered on an innovative mRNA vaccine platform designed for long-term storage at room temperature. Key development areas include vaccines for infectious diseases, immuno-therapeutic cancer vaccines, oral treatments for obesity, and therapies for eye conditions. Additionally, Dx & Vx provides contract development, manufacturing, and sales organization (CDMO/CSO) services and commercializes microbiome-based products and health supplements.

Recent filings

Filing Released Lang Actions
금전대여결정
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Decision to Lend Money' (금전대여결정) by DXVX to its subsidiary. It details the transaction amount, interest rate, purpose, and board approval status. This type of disclosure is a standard regulatory filing in the Korean market (DART system) for material corporate events that do not fall into specific categories like M&A or dividends. Since it is a specific regulatory announcement of a corporate action, it is best classified as a Regulatory Filing (RNS).
2025-04-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (Im Jong-yoon and others) in the company DXVX. This type of filing is specifically used to notify the market of significant changes in shareholding percentages, which falls under the 'Major Shareholding Notification' category.
2025-04-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the acquisition of shares by a director/major shareholder (Lim Jong-yoon) of DXVX. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2025-04-09 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. It details the acquisition of shares by an individual (Park Young Ok) in the company DXXVX (디엑스앤브이엑스(주)), resulting in a change in shareholding percentage. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) under the provided schema, as it tracks changes in significant ownership levels.
2025-04-04 Korean
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (DXVX) regarding the 'Acquisition of bonds before maturity after issuance of convertible bonds'. It details a correction to a previous filing (dated 2024-03-08) specifically regarding the future treatment of the acquired bonds (changing from 'to be determined' to 'cancellation'). This type of disclosure regarding capital structure, debt management, and specifically the cancellation of convertible bonds falls under the category of capital and financing updates.
2025-04-02 Korean
[기재정정]전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a South Korean company (DXVX) regarding the 'Acquisition of bonds before maturity' (specifically convertible bonds). It details a correction (amendment) to a previous filing concerning the disposal method of the acquired bonds (changing from 'to be determined' to 'cancellation'). This type of corporate action regarding debt instruments and capital structure changes falls under the 'Regulatory Filings' category as it is a specific disclosure of a corporate event that does not fit into the other specialized categories like M&A, Share Issues, or Dividends.
2025-04-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.